NuoHerb Nordic: Hope to become a reliable long-term partner in China.

Recently, Lars Fruergaard Jorgensen, Chairman of the Board of Danish pharmaceutical giant Novo Nordisk, highly praised the Chinese government for setting clear goals and systematic planning in dealing with chronic diseases, such as the "Healthy China 2030 Planning Outline" issued by China. He emphasized that Novo Nordisk hopes to become a reliable long-term partner for the Chinese government in the medical and health field.